SRPT - CIK 0000873303
Sarepta Therapeutics, Inc. has filed 1,504 documents with the SEC between 1997 and 2026. The most frequent type is insider trade (570 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Insider trade | 4 | 2025-09-05 | 2025-09-03 |
| Insider trade | 4 | 2025-09-05 | 2025-09-03 |
| Insider trade | 4 | 2025-09-05 | 2025-09-03 |
| Insider trade | 4 | 2025-09-05 | 2025-09-03 |
| Major company event | 8-K | 2025-08-29 | 2025-08-28 |
| Major company event | 8-K | 2025-08-21 | 2025-08-18 |
| SCHEDULE 13G/A | - | 2025-08-13 | - |
| Major company event | 8-K | 2025-08-13 | 2025-08-12 |
| Employee stock plan | S-8 | 2025-08-06 | - |
| Insider trade | 4 | 2025-08-06 | 2025-08-05 |
| Insider trade | 4 | 2025-08-06 | 2025-08-05 |
| Insider trade | 4 | 2025-08-06 | 2025-08-05 |
| Quarterly report | 10-Q | 2025-08-06 | 2025-06-30 |
| Insider trade | 4 | 2025-08-04 | 2025-07-31 |
| New insider ownership | 3 | 2025-08-04 | 2025-07-16 |
| SCHEDULE 13G/A | - | 2025-07-25 | - |
| SCHEDULE 13G | - | 2025-07-25 | - |
| Major company event | 8-K | 2025-07-21 | 2025-07-21 |
| Major company event | 8-K | 2025-07-16 | 2025-07-14 |
| Major company event | 8-K | 2025-06-06 | 2025-06-05 |
| Insider trade | 4 | 2025-05-19 | 2025-05-16 |
| Insider trade | 4 | 2025-05-15 | 2025-05-13 |
| Quarterly report | 10-Q | 2025-05-06 | 2025-03-31 |
| Annual report to shareholders | ARS | 2025-04-24 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-24 | - |
| Proxy statement | DEF 14A | 2025-04-24 | 2025-06-05 |
| Insider trade | 4 | 2025-03-13 | 2025-03-12 |
| Insider sale notice | 144 | 2025-03-12 | - |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-07 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-07 |
| Insider trade | 4 | 2025-03-11 | 2025-03-07 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-11 | 2025-03-10 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| Insider trade | 4 | 2025-03-10 | 2025-03-07 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| Insider trade | 4 | 2025-03-06 | 2025-03-04 |
| Insider trade | 4 | 2025-03-06 | 2025-03-04 |
| Insider trade | 4 | 2025-03-06 | 2025-03-04 |
| Insider trade | 4 | 2025-03-06 | 2025-03-04 |